Results from the First-in-Human Study of the Caterpillar (TM) Arterial Embolization System

Andrew Holden, Bibombe P. Mwipatayi, Manar Khashram, Steven Dubenec, Gerard S. Goh, Richard A. Settlage

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Purpose To assess occlusion success and adverse events associated with the use of a self-expanding device for peripheral artery embolization. Methods This prospective, single-arm, feasibility study was conducted using the Caterpillar (TM) Arterial Embolization Device composed of opposing nitinol fibers and a flow-occluding membrane. Twenty patients (24 embolization sites) were treated at four investigational centers in New Zealand and Australia and followed for 30 days. Embolization sites included mesenteric, accessory renal, and iliac arteries and their branches. Primary outcome measures were peri-procedural occlusion confirmed by angiography and freedom from device-related serious adverse events (SAEs) at 30 days. Secondary observations included time to occlusion and assessment of adverse events. Results Peri-procedural occlusion was 100%, and freedom from a device-related SAE was 94.7% at 30 days. One patient had abdominal bloating that required hospitalization deemed possibly related to the device or procedure. Twenty-two of 24 embolization sites were occluded with one device (91.7%). Mean procedure duration was 11.7 +/- 8.6 min (device deployment time: 1.8 +/- 1.0 min), and mean fluoroscopy time was 241 +/- 290.7 s. All embolization sites occluded during the procedure with 62.5% occluded within three minutes and 91.6% occluded within ten minutes. No devices migrated or required re-embolization. Freedom from device- and procedure-related adverse events was 84.2%. One patient died from aortic rupture during a subsequent adjunctive abdominal aortic endovascular procedure deemed unrelated to the embolization device or procedure. Conclusions This first-in-human study of the Caterpillar embolization device achieved peri-procedural occlusion in all patients with a 94.7% freedom from device-related SAE at 30 days.

Original languageEnglish
Pages (from-to)100-111
Number of pages12
JournalCardiovascular and Interventional Radiology
Volume46
Issue number1
DOIs
Publication statusPublished - Jan 2023

Fingerprint

Dive into the research topics of 'Results from the First-in-Human Study of the Caterpillar (TM) Arterial Embolization System'. Together they form a unique fingerprint.

Cite this